Beyond pharmaceutical manufacturer assistance: Broadening the scope of an indigent drug program

被引:26
|
作者
Weiner, S
Dischler, J
Horvitz, C
机构
[1] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Social Serv Representat, Chicago, IL USA
关键词
ambulatory care; charity; economics; health benefit programs; health care; industry; pharmaceutical; pharmaceutical services; pharmacists; prescriptions; sociology;
D O I
10.1093/ajhp/58.2.146
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A medication assistance program at a university medical center is described. The program was implemented in July 1999 by the ambulatory care pharmacy at the University of Illinois at Chicago Medical Center (UICMC). A full-time pharmacist and a full-time social worker run the program, along with support from technicians and a student extern. The program functions like a clinic, with both scheduled appointments and drop-ins. Patients are referred by UICMC providers or may self-refer. Sources of assistance include Medicaid, Medicare Part B, several state programs, manufacturers' programs, drug samples, private insurance plans and HMOs, and the patients themselves in the form of small payments. Patients receive medications at UICMC's expense only as a last resort. The medication assistance program helped 231 patients in the six months from July to December 1999. Program costs totaled $110,537, but $237,985 was saved. Only 13% of the savings came from pharmaceutical companies; 63% came from Medicaid. Experience with the program suggests that medication assistance initiatives should be structured to tap the full spectrum of resources for indigent patients, that programs be staffed by personnel with relevant experience, that program staff be prepared to work closely with patients and to follow up, and that the institution's charitable goods and services be restricted to patients for whom there are no other resources. A highly proactive medication assistance program at a university medical center improves the access of indigent patients to medications and is cost-effective.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [31] Sustained Funding for the AIDS Drug Assistance Program (ADAP)
    不详
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2012, 23 (02): : 177 - 178
  • [32] A Qualitative Study of Underutilization of the AIDS Drug Assistance Program
    Olson, Kristin M.
    Godwin, Noah C.
    Wilkins, Sara Anne
    Mugavero, Michael J.
    Moneyham, Linda D.
    Slater, Larry Z.
    Raper, James L.
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2014, 25 (05): : 392 - 404
  • [33] A cost-benefit analysis of an outpatient, pharmacy-managed medication assistance program for indigent patients.
    Gillespie, EL
    Henyan, NN
    Sander, S
    Gousse, GC
    Coleman, GI
    PHARMACOTHERAPY, 2005, 25 (10): : 1476 - 1476
  • [34] Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
    Cockburn, IM
    Henderson, RM
    JOURNAL OF HEALTH ECONOMICS, 2001, 20 (06) : 1033 - 1057
  • [35] Utilizing clinical pharmacists and a medication assistance program to improve medication access for indigent and underserved patients in primary care
    Pickett, Brianna
    Shin, Tiffany R.
    Norton, Melissa
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2023, 9
  • [36] Pharmaceutical humanitarian assistance in the establishment of a drug compounding laboratory in a refugee camp
    del Cacho-del Cacho, Maria Elena
    Lamin-Abdi, Mohamed
    Masoud-Mohamed, Mulay
    Luanco-Berdiel, Victoria
    Cofan-Pujol, Montse
    Azman-Hosein, Salama
    Castells-Lao, Genis
    Codina-Jane, Carlos
    FARMACIA HOSPITALARIA, 2021, 45 (05) : 262 - 267
  • [37] Patient cost savings through the use of pharmaceutical manufacturer assistance programs in a private ambulatory care setting.
    Sarrafizadeh, M
    Waite, NM
    Hobson, EH
    Migden, H
    PHARMACOTHERAPY, 2002, 22 (10): : 1383 - 1384
  • [39] PROVIDING DRUG INFORMATION TO HEALTH-PROFESSIONALS AND CONSUMERS - ROLE AND RESPONSIBILITY OF THE PHARMACEUTICAL MANUFACTURER
    BOYLAND, JI
    DREXEL LIBRARY QUARTERLY, 1982, 18 (02): : 11 - 21
  • [40] PREDICTORS OF MEDICATION ADHERENCE AMONG ELDERLY STATE PHARMACEUTICAL ASSISTANCE PROGRAM BENEFICIARIES
    Pednekar, P.
    Peterson, A. M.
    VALUE IN HEALTH, 2019, 22 : S158 - S158